Pyrethrum Pediculicide Labeling Revisions Advised In FDA Amendment
This article was originally published in The Rose Sheet
Executive Summary
FDA's proposed amendment of the final monograph for OTC pediculicide products would appear to bring labeling for drugs included in the monograph in line with that of lice preparations covered under an NDA